Skip to content

Feasibility and Effects of Activity Trackers Among Alcohol Users Receiving In-patient Treatment for Alcohol Use Disorder

Feasibility and Effects of Activity Trackers Among Alcohol Users Receiving In-patient Treatment for Alcohol Use Disorder

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06629493
Enrollment
90
Registered
2024-10-08
Start date
2022-04-04
Completion date
2025-07-02
Last updated
2026-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol-Related Disorders, Alcohol Use Disorder (AUD), Substance-Related Disorders

Keywords

activity tracker, alcohol use disorder, physical activity, treatment, mental health

Brief summary

The main objective is to assess the feasibility and effectiveness of using activity trackers to increase physical activity and improve the emotional state of people receiving an in-patient treatment for alcohol use disorder

Interventions

BEHAVIORALFitbit Versa 3

Fitbit Versa 3 is a commercially available activity tracker

BEHAVIORALIn-patient alcohol use disorder treatment

In-patient alcohol use disorder treatment, including group therapy, counseling, and occupational activities

Sponsors

University of Oviedo
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Being 18 years old or older. * Be undergoing inpatient treatment for alcohol use disorder.

Exclusion criteria

* Finishing the in-treatment before 4 weeks.

Design outcomes

Primary

MeasureTime frameDescription
Physical activity tracker adherenceTreatment duration (4 weeks)Days (percentage) in which activity tracker was used (day-time and night-time use)
Physical activity tracker perceived utilityEnd-of-treatment (4 weeks)Perceived utility with the physical activity tracker will be assessed using ad-hoc questions about the utility of the activity tracker to increase levels of physical activity, improve sleep quality, and reduce/abandon tobacco.
Physical activity levelsIn-treatment (4 weeks), from enrollment to end-of treatment (4 weeks)Physical activity (PA) is operationalized as steps per day, plants climbed per day, distance covered per day (kilometers), light physical activity (minutes per day), moderate physical activity (minutes per week), vigorous physical activity (minutes per week), and sedentary time (hours per day). These outcomes will be measured using an adapted version of the International Physical Activity Questionnaire (IPAQ) and Fitbit Versa 3®.
Depression symptomsFrom enrollment to the end-of-treatment (4 weeks)Depression symptoms will be measured using the Patient Health Questionnaire-9 (PHQ-9). This questionnaire ranges from 0 to 14. A higher punctuation means higher depression symptom levels.
Anxiety symptomsFrom enrollment to the end-of-treatment (4 weeks)Anxiety symptoms will be measured using Generalized Anxiety Disorder-7 (GAD-7). This questionnaire ranges from 0 to 21. Higher punctuation means higher anxiety levels symptoms.
Difficulties in emotion regulationFrom enrollment to the end-of-treatment (4 weeks)Emotion dysregulation is measured using the Difficulties in Emotion Regulation Scale (DERS). Emotional dysregulation of negative emotions is measured with the Difficulties in Emotion Regulation Scale (DERS). This scale ranges from 28 to 140 points. A higher score means more difficulties in emotion regulation.
Physical activity tracker acceptabilityEnd-of-treatment (4 weeks)Acceptability of the activity tracker is measured using the Participant Experience Questionnaire (PEQ). This scale ranges from 10 to 50 points. A higher score means higher acceptability.
Sleep qualityIn-treatment (4 weeks), from enrollment to the end-of-treatment (4 weeks)Sleep quality will be measured using both the Pittsburg Sleep Quality Index (PSQI) and the Fitbit Versa 3. PSQI ranges from 0 to 21 points. A higher score means lower sleep quality. In addition, Fitbit Versa 3 provides a sleep quality punctuation ranging from 0 to 100. A higher punctuation means better sleep quality.

Secondary

MeasureTime frameDescription
Tobacco useIn treatment (4 weeks), from enrollment to the end-of-treatment (4 weeks)Self-reported cigarettes per day and carbon monoxide (CO) levels measured by a CO monitor reading.
Delay discounting (impulsive decision making)From enrollment to the end-of-treatment (4 weeks)Delay discounting will be measured using the 21-item Monetary-Choice task. Computerized Delay Discounting task of tobacco (delay of one day, one week, one month, and six months).

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 28, 2026